e-learning
resources
Berlin 2008
Wednesday, 08.10.2008
COPD
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Use of B-type natriuretic peptide in the risk stratification of acute exacerbations of chronic obstructive pulmonary disease
D. Stolz, T. Breidthardt, M. Christ-Crain, R. Bingisser, D. Miedinger, J. Leuppi, B. Müller, M. Tamm, C. Müller (Basel, Switzerland)
Source:
Annual Congress 2008 - COPD
Session:
COPD
Session type:
E-Communication Session
Number:
4665
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
D. Stolz, T. Breidthardt, M. Christ-Crain, R. Bingisser, D. Miedinger, J. Leuppi, B. Müller, M. Tamm, C. Müller (Basel, Switzerland). Use of B-type natriuretic peptide in the risk stratification of acute exacerbations of chronic obstructive pulmonary disease. Eur Respir J 2008; 32: Suppl. 52, 4665
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Thierry Rochat - 08.10.2008 10:13
question
Did you also do a ROC analysis for ICU amission and how does it look like ?
You must
Login
to comment this presentation.
Related content which might interest you:
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
The role of amino-terminal pro-brain natriuretic peptide (NT-proBNP in clinical evaluation of patient with acute exacerbation chronic obstructive pulmonary disease
Source: International Congress 2014 – ICU outcomes, sepsis and infections
Year: 2014
Brtain natriuretic peptide in chronic obstructive pulmonary disease under stable state and respiratory failure
Source: Eur Respir J 2003; 22: Suppl. 45, 269s
Year: 2003
The effect of diuretics on plasma brain natriuretic peptide level in patients with acute exacerbations of chronic obstructive pulmonary disease
Source: Annual Congress 2007 - Treatment of COPD
Year: 2007
Brain natriuretic peptides in patients with idiopathic pulmonary hypertension and chronic thromboembolic disease
Source: Annual Congress 2007 - Venous thromboembolic disease
Year: 2007
Identification of left ventricular systolic dysfunction or pulmonary hypertension in patients with asthma or chronic obstructive pulmonary disease by N-terminal pro-brain natriuretic peptide
Source: Annual Congress 2007 - New insight into the pathophysiology of asthma
Year: 2007
The effects of elevated troponin I on long-term mortality after chronic obstructive pulmonary disease exacerbation
Source: Annual Congress 2009 - COPD: exacerbation and clinical problems
Year: 2009
Pro-adrenomedullin and pro-endothelin-1 for assessment and prognosis of acute exacerbation of chronic obstructive pulmonary disease (AECOPD)
Source: Eur Respir J 2007; 30: Suppl. 51, 39s
Year: 2007
Atrial fibrillation as a relevant comorbidity in patients with acute exacerbation of chronic obstructive pulmonary disease
Source: International Congress 2017 – Classifying COPD with multidimensional scores and biomarkers
Year: 2017
Elevation of cardiac troponin-I predicts long-term mortality in patients with acute exacerbation of chronic obstructive pulmonary disease
Source: Annual Congress 2009 - Biomarkers and biology in COPD
Year: 2009
Cardiac biomarkers and outcome in patients with acute exacerbation of chronic obstructive pulmonary disease
Source: Annual Congress 2012 - COPD exacerbation
Year: 2012
Acute coronary events during acute exacerbations of chronic obstructive pulmonary disease
Source: Annual Congress 2007 - Clinical aspects in COPD
Year: 2007
N-terminal pro-brain natriuretic peptide is a useful prognostic marker in patients with pulmonary hypertension and renal insufficiency
Source: Annual Congress 2013 –Pulmonary circulation: clinical pulmonary hypertension I
Year: 2013
Predictors of high-sensitivity cardiac troponin T during acute exacerbation of chronic obstructive pulmonary disease
Source: Annual Congress 2011 - Respiratory epidemiology: comorbidity
Year: 2011
Risk factors for early readmission after acute exacerbation of chronic obstructive pulmonary disease
Source: Virtual Congress 2020 – Prediction of outcomes in obstructive diseases
Year: 2020
The diagnostic value of N-terminal pro-C-type natriuretic peptide in COPD patients with pulmonary hypertension
Source: International Congress 2015 – Pulmonary hypertension in lung disease
Year: 2015
Acute exacerbations of chronic obstructive pulmonary disease: Impact of cardiovascular co-morbidities
Source: Annual Congress 2010 - Risk factors, prevalence and consequences of COPD
Year: 2010
The role of neutrophil/lymphocyte ratio in acute exacerbations of chronic obstructive pulmonary disease COPD
Source: Virtual Congress 2020 – Investigations of COPD
Year: 2020
Heart arrhythmias in patients with chronic obstructive bronchitis and ischemic heart disease
Source: Eur Respir J 2004; 24: Suppl. 48, 277s
Year: 2004
NT-proBNP, troponin T and left ventricular function in patients with acute exacerbation of chronic obstructive pulmonary disease
Source: Annual Congress 2012 - COPD comorbidities II
Year: 2012
Troponin T elevation and long-term mortality after chronic obstructive pulmonary disease exacerbation
Source: Eur Respir J 2008; 31: 563-570
Year: 2008
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept